CMPX vs REG · $367.4M cap vs P/E 34, $12.93B cap
Compass Therapeutics Inc. (CMPX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
CMPX does not have a complete income-statement cache yet.
REG does not have a complete income-statement cache yet.
CMPX currently screens at market cap $367.4M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the CMPX and REG stock pages for the full models.
Not investment advice.